27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
Following the 90-percent year-to-date appreciation in Intercept Pharmaceutical, Inc. (NASDAQ:ICPT) shares, RBC Capital Markets considers the stock's risk-reward to be balanced.
The Analyst
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
RBC Capital Markets analyst Brian Abrahams downgraded Intercept from Outperform to Sector Perform with a $115 price target.
The Thesis
RBC remains positive on the company’s Regenerate trial for patients with advanced liver fibrosis, Abrahams said in the Wednesday downgrade note. (See the analyst's track record here.)
“ ... We continue to believe the interim REGENERATE analysis [the first half of 2019] is more likely than not to be positive,” the analyst said.
FREE REPORT: How To Learn Options Trading Fast
In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.
The balanced reward-risk valuation is driven by the considerable rise in share price, Abrahams said. While expectations for trials such as REGENERATE and NASH have not altered, the analyst said they were overly discounted before the run-up.
Peer NASH company valuations illustrate similar expectations, Abrahams said.
“Interestingly, we note that the gap in valuation between ICPT and Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) has closed ... further suggesting we may have reached a more balanced relative level."
Price Action
Intercept shares were trading down 7.3 percent to $103.50 at the time of publication Wednesday.
Related Links:
Analysts Split On How To Read Intercept Switching Clinical Trial Endpoints
Will Intercept Stock Potential Be Blindsided By FDA Letter?
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.